# Janux Therapeutics, Inc.: Form 8-K, filed Dec 5, 2024

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: 8-K
- Filed: 2024-12-05
- Accepted by EDGAR: Dec 5, 2024, 16:32 ET
- Period: 2024-12-04
- Accession: 0001193125-24-271578
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/d877731d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000119312524271578/d877731d8k.htm

Filed Dec 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-271578. Last ingested by Listed: Nov 15, 2026, 00:55 ET. No prices; not investment advice.
